CHEST Annual Meeting Insights


 

CHEST 2024 Insights: Ensifentrine, a Novel COPD Treatment, Reduced COPD-Related Healthcare Resource Utilization Over 48 Weeks

1,448 views
October 25, 2024
Comments 0
Login to view comments. Click here to Login